{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:20:14Z","timestamp":1793974814789,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clozapine is the most effective antipsychotic drug for schizophrenia, yet it can cause life-threatening adverse drug reactions, including myocarditis. The aim of this study was to determine whether schizophrenia patients with clozapine-induced myocarditis have a genetic predisposition compared with clozapine-tolerant controls. We measured different types of genetic variation, including genome-wide single-nucleotide polymorphisms (SNPs), coding variants that alter protein expression, and variable forms of human leucocyte antigen (HLA) genes, alongside traditional clinical risk factors in 42 cases and 67 controls. We calculated a polygenic risk score (PRS) based on variation at 96 different genetic sites, to estimate the genetic liability to clozapine-induced myocarditis. Our genome-wide association analysis identified four SNPs suggestive of increased myocarditis risk (<jats:italic>P<\/jats:italic>\u2009&lt;\u20091\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>), with odds ratios ranging 5.5\u201313.7. The SNP with the lowest <jats:italic>P<\/jats:italic> value was rs74675399 (chr19p13.3, <jats:italic>P<\/jats:italic>\u2009=\u20091.21\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>; OR\u2009=\u20096.36), located in the <jats:italic>GNA15<\/jats:italic> gene, previously associated with heart failure. The <jats:italic>HLA-C*07:01<\/jats:italic> allele was identified as potentially predisposing to clozapine-induced myocarditis (OR\u2009=\u20092.89, 95% CI: 1.11\u20137.53), consistent with a previous report of association of the same allele with clozapine-induced agranulocytosis. Another seven HLA alleles, including <jats:italic>HLA-B*07:02<\/jats:italic> (OR\u2009=\u20090.25, 95% CI: 0.05\u20131.2) were found to be putatively protective. Long-read DNA sequencing provided increased resolution of HLA typing and validated the HLA associations. The PRS explained 66% of liability (<jats:italic>P<\/jats:italic> value\u2009=\u20099.7\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>). Combining clinical and genetic factors together increased the proportion of variability accounted for (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup> 0.73, <jats:italic>P<\/jats:italic>\u2009=\u20099.8\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>). However, due to the limited sample size, individual genetic associations were not statistically significant after correction for multiple testing. We report novel candidate genetic associations with clozapine-induced myocarditis, which may have potential clinical utility, but larger cohorts are required for replication.<\/jats:p>","DOI":"10.1038\/s41398-020-0722-0","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T15:06:30Z","timestamp":1581951990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Genetic associations with clozapine-induced myocarditis in patients with schizophrenia"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0902-6798","authenticated-orcid":false,"given":"Paul","family":"Lacaze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-009X","authenticated-orcid":false,"given":"Kathlyn J.","family":"Ronaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alfirevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Strahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rossello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Vasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sebra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"722_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","volume":"173","author":"TS Stroup","year":"2016","unstructured":"Stroup, T. S., Gerhard, T., Crystal, S., Huang, C. & Olfson, M. Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia. Am. J. Psychiatry 173, 166\u2013173 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht, S. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382, 951\u2013962 (2013).","journal-title":"Lancet"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1192\/S0007125000296906","volume":"17","author":"P Krupp","year":"1992","unstructured":"Krupp, P. & Barnes, P. Clozapine-associated agranulocytosis: risk and aetiology. Br. J. Psychiatry Suppl. 17, 38\u201340 (1992).","journal-title":"Br. J. Psychiatry Suppl."},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40263-018-0587-4","volume":"33","author":"S Every-Palmer","year":"2019","unstructured":"Every-Palmer, S., Inns, S. J., Grant, E. & Ellis, P. M. Effects of clozapine on the gut: cross-sectional study of delayed gastric emptying and small and large intestinal dysmotility. CNS Drugs 33, 81\u201391 (2019).","journal-title":"CNS Drugs"},{"key":"722_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/acps.12416","volume":"132","author":"KJ Ronaldson","year":"2015","unstructured":"Ronaldson, K. J., Fitzgerald, P. B. & McNeil, J. J. Clozapine-induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatr. Scand. 132, 231\u2013240 (2015).","journal-title":"Acta Psychiatr. Scand."},{"key":"722_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/00048674.2011.572852","volume":"45","author":"KJ Ronaldson","year":"2011","unstructured":"Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J., Topliss, D. J. & McNeil, J. J. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust. N. Z. J. Psychiatry 45, 458\u2013465 (2011).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"722_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.schres.2012.08.018","volume":"141","author":"KJ Ronaldson","year":"2012","unstructured":"Ronaldson, K. J. et al. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophr. Res. 141, 173\u2013178 (2012).","journal-title":"Schizophr. Res."},{"key":"722_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung, W. H. et al. Medical genetics: a marker for Stevens\u2212Johnson syndrome. Nature 428, 486 (2004).","journal-title":"Nature"},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal, S. et al. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568\u2013579 (2008).","journal-title":"N. Engl. J. Med."},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/00002030-199907300-00026","volume":"13","author":"L Escaut","year":"1999","unstructured":"Escaut, L., Liotier, J. Y., Albengres, E., Cheminot, N. & Vittecoq, D. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. AIDS 13, 1419\u20131420 (1999).","journal-title":"AIDS"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4088\/JCP.11l07467","volume":"73","author":"KJ Ronaldson","year":"2012","unstructured":"Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J. & McNeil, J. J. Observations from 8 cases of clozapine rechallenge after development of myocarditis. J. Clin. Psychiatry 73, 252\u2013254 (2012).","journal-title":"J. Clin. Psychiatry"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/0004867411433970","volume":"46","author":"KJ Ronaldson","year":"2012","unstructured":"Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J. & McNeil, J. J. Continuation of clozapine following mild myocarditis. Aust. N. Z. J. Psychiatry 46, 910\u2013911 (2012).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"722_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4088\/JCP.09m05024yel","volume":"71","author":"KJ Ronaldson","year":"2010","unstructured":"Ronaldson, K. J. et al. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J. Clin. Psychiatry 71, 976\u2013981 (2010).","journal-title":"J. Clin. Psychiatry"},{"key":"722_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"722_CR15","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","volume":"31","author":"J Euesden","year":"2015","unstructured":"Euesden, J., Lewis, C. M. & O\u2019Reilly, P. F. PRSice: Polygenic Risk Score software. Bioinformatics 31, 1466\u20131468 (2015).","journal-title":"Bioinformatics"},{"key":"722_CR16","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.4049\/jimmunol.174.11.7085","volume":"174","author":"IA Doytchinova","year":"2005","unstructured":"Doytchinova, I. A. & Flower, D. R. In silico identification of supertypes for class II MHCs. J. Immunol. 174, 7085\u20137095 (2005).","journal-title":"J. Immunol."},{"key":"722_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9, 1\u201315 (2008).","journal-title":"BMC Immunol."},{"key":"722_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"722_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279\u2013284 (2001).","journal-title":"Behav. Brain Res."},{"key":"722_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","volume":"3","author":"NL Smith","year":"2010","unstructured":"Smith, N. L. et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circulation Cardiovascular Genet. 3, 256\u2013266 (2010).","journal-title":"Circulation Cardiovascular Genet."},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonz\u00e1lez-Galarza","year":"2015","unstructured":"Gonz\u00e1lez-Galarza, F. F. et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43, D784\u2013D788 (2015).","journal-title":"Nucleic Acids Res."},{"key":"722_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00008571-200103000-00004","volume":"11","author":"M Dettling","year":"2001","unstructured":"Dettling, M., Schaub, R. T., Mueller-Oerlinghausen, B., Roots, I. & Cascorbi, I. Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry. Pharmacogenetics 11, 135\u2013141 (2001).","journal-title":"Pharmacogenetics"},{"key":"722_CR23","first-page":"S97","volume":"2018","author":"C Bousman","year":"2018","unstructured":"Bousman, C. et al. The Pharmacogenomics of Clozapine-Induced myocarditis (PROCLAIM) Consortium. ACNP 57(th) Annual Meeting: Poster Session III. Neuropsychopharmacology 2018, S97\u2013S98 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"722_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/tpj.2017.6","volume":"17","author":"SAJ de With","year":"2017","unstructured":"de With, S. A. J., Pulit, S. L., Staal, W. G., Kahn, R. S. & Ophoff, R. A. More than 25 years of genetic studies of clozapine-induced agranulocytosis. Pharmacogenomics J. 17, 304\u2013311 (2017).","journal-title":"Pharmacogenomics J."},{"key":"722_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/mp.2016.137","volume":"22","author":"SE Legge","year":"2017","unstructured":"Legge, S. E. et al. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Mol. Psychiatry 22, 1509 (2017).","journal-title":"Mol. Psychiatry"},{"key":"722_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","volume":"134","author":"P Manu","year":"2012","unstructured":"Manu, P., Sarpal, D., Muir, O., Kane, J. M. & Correll, C. U. When can patients with potentially life-threatening adverse effects be re-challenged with clozapine? A systematic review of the published literature. Schizophrenia Res. 134, 180\u2013186 (2012).","journal-title":"Schizophrenia Res."},{"key":"722_CR27","doi-asserted-by":"crossref","first-page":"117863101772117","DOI":"10.1177\/1178631017721178","volume":"10","author":"HMK Kuo","year":"2017","unstructured":"Kuo, H. M. K. Multiple testing in the context of gene discovery in sickle cell disease using genome-wide association studies. Genom. Insights 10, 1178631017721178 (2017).","journal-title":"Genom. Insights"},{"key":"722_CR28","doi-asserted-by":"publisher","first-page":"19125","DOI":"10.1074\/jbc.272.31.19125","volume":"272","author":"GJ Della Rocca","year":"1997","unstructured":"Della Rocca, G. J. et al. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gqmediated pathways on calcium\/calmodulin, Pyk2, and Src kinase. J. Biol. Chem. 272, 19125\u201319132 (1997).","journal-title":"J. Biol. Chem."},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/ajmg.a.35886","volume":"161A","author":"S Peddibhotla","year":"2013","unstructured":"Peddibhotla, S. et al. Expanding the genotype-phenotype correlation in subtelomeric 19p13.3 microdeletions using high resolution clinical chromosomal microarray analysis. Am. J. Med. Genet. A 161A, 2953\u20132963 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"722_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nchembio.642","volume":"7","author":"K Qin","year":"2011","unstructured":"Qin, K., Dong, C., Wu, G. & Lambert, N. A. Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers. Nat. Chem. Biol. 7, 740\u2013747 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"722_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1677\/JME-09-0134","volume":"44","author":"F Giannone","year":"2010","unstructured":"Giannone, F. et al. The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis. J. Mol. Endocrinol. 44, 259\u2013269 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"722_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yexmp.2017.08.005","volume":"103","author":"SW French","year":"2017","unstructured":"French, S. W. et al. The role of the IL-8 signaling pathway in the infiltration of granulocytes into the livers of patients with alcoholic hepatitis. Exp. Mol. Pathol. 103, 137\u2013140 (2017).","journal-title":"Exp. Mol. Pathol."},{"key":"722_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001092","volume":"8","author":"V Suppiah","year":"2011","unstructured":"Suppiah, V. et al. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med. 8, e1001092 (2011).","journal-title":"PLoS Med."},{"key":"722_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/14622416.7.6.813","volume":"7","author":"A Alfirevic","year":"2006","unstructured":"Alfirevic, A. et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7, 813\u2013818 (2006).","journal-title":"Pharmacogenomics"},{"key":"722_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.apha.2018.03.002","volume":"83","author":"O Osanlou","year":"2018","unstructured":"Osanlou, O., Pirmohamed, M. & Daly, A. K. Pharmacogenetics of adverse drug reactions. Adv. Pharmacol. 83, 155\u2013190 (2018).","journal-title":"Adv. Pharmacol."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0722-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:00:59Z","timestamp":1670248859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-0722-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"37"}}